A feasibility assessment of real-world data capabilities for monitoring vaccine safety and effectiveness in China: human papillomavirus vaccination in the Yinzhou district as a use case.

This feasibility assessment indicates that the YRHIP has the capacity to capture demographic, exposure, outcome and other data required to generate RWE on HPV vaccine safety and effectiveness in China. Studies using the YRHIP to monitor the AS04-HPV-16/18 vaccine in routine use building on this feasibility assessment are ongoing. This article is protected by copyright. All rights reserved.